Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
aTyr Pharma, Inc. (ATYR) had Cash Flow from Financial Activities of $66.01M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-13.96M |
|
-- |
|
-- |
|
$14.80M |
|
$-14.80M |
|
$0.83M |
|
$-13.96M |
|
$-13.96M |
|
$-13.96M |
|
$-13.96M |
|
$-13.96M |
|
$-13.96M |
|
$-14.80M |
|
$-14.76M |
|
92.99M |
|
92.99M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$80.24M |
|
$4.26M |
|
$12.77M |
|
$93.00M |
|
$15.15M |
|
$0.26M |
|
$10.57M |
|
$25.71M |
|
$67.29M |
|
$67.29M |
|
$67.29M |
|
98.03M |
|
| Cash Flow Statement Financials | |
$-61.99M |
|
$-5.05M |
|
|
Cash Flow from Financial Activities |
$66.01M |
$14.01M |
|
$12.98M |
|
$-1.03M |
|
$5.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.30 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-62.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.75% |
|
-20.75% |
|
-15.01% |
|
-20.67% |
|
$0.69 |
|
$-0.67 |
|
$-0.67 |
|